Similar articles for PMID: 27984060

Year	Number of Results
1998	1
2002	1
2003	2
2004	2
2005	2
2006	4
2007	9
2008	6
2009	7
2010	9
2011	9
2012	12
2013	22
2014	30
2015	30
2016	30
2017	24
2018	27
2019	26
2020	17
2021	24
2022	22
2023	6
2024	0

1

Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine.

Ikram A, Obaid A, Awan FM, Hanif R, Naz A, Paracha RZ, Ali A, Janjua HA. Ikram A, et al. Antiviral Res. 2017 Jan;137:112-124. doi: 10.1016/j.antiviral.2016.10.013. Epub 2016 Oct 28. Antiviral Res. 2017. PMID: 27984060

2

Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.

Prabdial-Sing N, Blackard JT, Puren AJ, Mahomed A, Abuelhassan W, Mahlangu J, Vermeulen M, Bowyer SM. Prabdial-Sing N, et al. Antiviral Res. 2016 Mar;127:90-8. doi: 10.1016/j.antiviral.2015.11.011. Epub 2015 Dec 17. Antiviral Res. 2016. PMID: 26704023

3

Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients.

El-Tahan RR, Ghoneim AM, Zaghloul H. El-Tahan RR, et al. Virus Genes. 2020 Oct;56(5):564-581. doi: 10.1007/s11262-020-01776-y. Epub 2020 Jun 22. Virus Genes. 2020. PMID: 32572756 Free PMC article.

4

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.

Lindström I, Kjellin M, Palanisamy N, Bondeson K, Wesslén L, Lannergard A, Lennerstrand J. Lindström I, et al. Infect Dis (Lond). 2015 Aug;47(8):555-62. doi: 10.3109/23744235.2015.1028097. Epub 2015 Apr 8. Infect Dis (Lond). 2015. PMID: 25851241

5

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.

Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, McCaughan G, Shackel N, Jeffrey GP, Mollison L, Baker R, Furrer H, Günthard HF, Freitas E, Humphreys I, Klenerman P, Mallal S, James I, Roberts S, Nolan D, Lucas M. Gaudieri S, et al. Hepatology. 2009 Apr;49(4):1069-82. doi: 10.1002/hep.22773. Hepatology. 2009. PMID: 19263475

6

[Determination of drug resistance mutations of NS3 inhibitors in chronic hepatitis C patients infected with genotype 1].

Şanlıdağ T, Sayan M, Akçalı S, Kasap E, Buran T, Arıkan A. Şanlıdağ T, et al. Mikrobiyol Bul. 2017 Apr;51(2):145-155. doi: 10.5578/mb.53824. Mikrobiyol Bul. 2017. PMID: 28566078 Free article. Turkish.

7

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.

Costantino A, Spada E, Equestre M, Bruni R, Tritarelli E, Coppola N, Sagnelli C, Sagnelli E, Ciccaglione AR. Costantino A, et al. Virol J. 2015 Nov 14;12:186. doi: 10.1186/s12985-015-0414-1. Virol J. 2015. PMID: 26577836 Free PMC article.

8

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

Dietz J, Susser S, Vermehren J, Peiffer KH, Grammatikos G, Berger A, Ferenci P, Buti M, Müllhaupt B, Hunyady B, Hinrichsen H, Mauss S, Petersen J, Buggisch P, Felten G, Hüppe D, Knecht G, Lutz T, Schott E, Berg C, Spengler U, von Hahn T, Berg T, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Gastroenterology. 2018 Mar;154(4):976-988.e4. doi: 10.1053/j.gastro.2017.11.007. Epub 2017 Nov 13. Gastroenterology. 2018. PMID: 29146520

9

Analysis of Naturally Occurring Resistance-Associated Variants to NS3/4A Protein Inhibitors, NS5A Protein Inhibitors, and NS5B Polymerase Inhibitors in Patients With Chronic Hepatitis C.

Sun D, Dai M, Shen S, Li C, Yan X. Sun D, et al. Gene Expr. 2018 Mar 21;18(1):63-69. doi: 10.3727/105221617X15100607143377. Epub 2017 Dec 8. Gene Expr. 2018. PMID: 29221500 Free PMC article.

10

Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.

Abdel-Hameed EA, Rouster SD, Ji H, Ulm A, Hetta HF, Anwar N, Sherman KE, Shata MT. Abdel-Hameed EA, et al. Viral Immunol. 2016 May;29(4):252-8. doi: 10.1089/vim.2015.0093. Epub 2016 Feb 17. Viral Immunol. 2016. PMID: 26885675 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

280 results

Results by year